CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases, today announced the pricing of its initial public offering of 12,100,000 shares of common stock at a price to the public of $16.00 per share. https://hubs.ly/Q011HrgZ0 Maina Bhaman Marc de Garidel Catherine J. Pearce, MBA, DHSc Terry Coelho Troy Ignelzi Justin R Thompson Mason Freeman John Thero Sofinnova Investments 5AM Ventures General Atlantic Cooley LLP Morgan Stanley Jefferies Evercore Oppenheimer & Co. Inc. Anta Gkelou
Anta Gkelou’s Post
More Relevant Posts
-
SofinnovaAI is amplifying our breakthrough discovery and feeding us scientific and clinical insights. Join us to contribute in accelerating innovation in Life Sciences. 💡 🔬 💊
Sofinnova Partners is looking for a full stack senior engineer to join the SofinnovaAI team and continue building the future of Venture Capital in Life Sciences! 🤓 If you are eager to use your skills to ease and improve investments in early-stage healthcare and sustainable companies, get in touch with Javier Nunez-Vicandi and Anta (Ada) Gkelou! Full time or part-time opportunity depending on your skillset and availability. Remote-friendly with some days in Paris's office (1 day / week at least). https://lnkd.in/d8X--_tK
-
🚀🚀🚀 We're thrilled to announce the successful close of Sofinnova Digital Medicine I at $200 million, significantly exceeding its target and marking the latest milestone in our expanding suite of investment strategies in life sciences. Partners Edward Kliphuis and Simon Turner are leading the strategy to support groundbreaking entrepreneurs at the nexus of #technology and #biology, propelling them to emerge as global frontrunners. We're concentrating on three pivotal areas: ➡️ Enabling Technologies that drive AI's role in health sciences ➡️ Analytics to refine patient understanding ➡️ Treatments that reshape patient behaviors for enhanced outcomes Edward Kliphuis said: "In just a few months since launching this strategy, we've executed five investments into transformative companies, including Kiro, BioCorteX, deepc, l'école AI, and Betteromics, which are fusing state-of-the-art computational methods with advanced biological innovations. Leveraging Sofinnova's 50-year expertise and network, we serve as allies to digital medicine pioneers, enabling them to secure product-market fit and scale on a global stage.” Simon Turner, said: “We bring Sofinnova’s deep healthcare expertise to entrepreneurs pioneering at the forefront of digital medicine where biology meets tech-industry approaches like rapid product iteration and accelerated commercialization. Our goal is to support innovators developing disruptive solutions for patients and health systems.” Antoine Papiernik, Chairman and Managing Partner of Sofinnova Partners, added: “The successful closing of Sofinnova Digital Medicine I above its target size marks yet another milestone in our growth as a global firm fostering disruptive innovations in life sciences. This newest fund in our platform of investment strategies is a testament to the trust our limited partners place in our vision and to Sofinnova’s longstanding commitment to shaping the future of healthcare.” Join us on this revolutionary journey! https://hubs.ly/Q026PznV0 Javier Nunez-Vicandi Aishwarya Parthasarathy Angela Lai Chetan Patel Jack Menzel Louis-Alexandre Etezad-Heydari Jonathan Alexander Brown Kim Nilsson Muhannad Alomari Nik Sharma Julia Moosbauer Dr. Franz MJ Pfister, MD, MBA Alexandre Guenoun #DigitalMedicine #Innovation #VC #fundraise
-
-
It was an honour to discuss diversity in healthcare innovation at the French Embassy 🇫🇷 in Athens 🇬🇷. Joined a dynamic panel of women in the driving seat of Innovation in Greece Antigoni Lymperopoulou Myrto Papathanou Thaleia Misailidou Lisa Katsouraki Thank you 🙏 La French Tech Athens Guy Krief and Madame l’Ambassadrice de France en Grèce Laurence Auer. Sofinnova Partners #europeaninnovation #greekinnovation
🇫🇷✨ Celebrating "Diverse Leaders Innovating Today" at the French Embassy in Athens. Yesterday, we discussed early-stage startups, the innovative strides of women in healthcare and biotech, the evolving dynamics of leadership in diverse corporate settings, the vision of investors shaping technology's future, and the transformative power of diversity in new teams and ventures. A heartfelt merci to Madame l'Ambassadrice de France en Grèce Laurence AUER for welcoming us in such a prestigious setting. We're also immensely grateful to all participants and our generous sponsors. Thank you 🙏 Elena Chailazopoulou Elena Barla, BEng, MEng, MBA Rania Lamprou Anna Natsvlishvili Georgia Tsiliki Electra Gizeli Yvoni Papastelatou Calie Sharman Rania Ekaterinari (Aikaterinari) Chrysa Karamanidi Dimitra Petridi Maria S. Antigoni Lymperopoulou Lisa Katsouraki Anta (Ada) Gkelou Thaleia Misailidou Lakis Gavalas Nassia Stouraiti katerina papanikolaou Kevin aka Negros Tou Moria Pascale Sourisse. Our sponsors 🙏 Piraeus Bank SPACE HELLAS S.A. Pernod Ricard PwC WHITE ad & PURPLE events The French Tech Athens Team 🇫🇷 Myrto Papathanou Stefi Vasilopoulou Effie Antiochou Guy Krief Daniel Fokas Jerome Bajou Theodore Albanidis Stavros Stavrides Dimitris Dimosiaris La French Tech
-
-
📣 On my way to the Inaugural Euretina Innovation Spotlight today at #Euretina2023 🇳🇱 💡I will be part of the panel representing Sofinnova Partners a leading EU VC investing in life sciences; #healthcare and #sustainability. Join us to discuss #investments in #innovative therapies for patients with retinal diseases. Thank you for the invitation to the organising committee, Euretina President and Euretina President Elect Kourous Rezaei, MD Alistair Laidlaw Ramin Tadayoni Hope to see you there! #RetinalCare #Opthalmology #Innovation #Euretina2023 #Amsterdam #EuropeanInnovation
-
Anta Gkelou reposted this
It is a great day for patients with Chronic Limb Threatening Ischemia! It has been an incredible journey so far in bringing this therapy to market and we are incredibly excited by the work ahead. I want to extend my deep gratitude to our investigators, advisors, investors and most importantly, the amazing LimFlow team who worked so hard for so long to make this day come true. #clti LimFlow SA
FDA Approves LimFlow System in Patients With Chronic Limb-Threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options
businesswire.com
-
Anta Gkelou reposted this
🙌 Congratulations to the incredible team at LimFlow SA, a Sofinnova portfolio company, on its #FDAapproval - a monumental achievement for the company and for patients who would otherwise face amputation. This is a significant milestone in the fight against chronic limb-threatening ischemia #CTLI, a severe form of peripheral artery disease that affects millions, resulting in a staggering number of major limb amputations each year. The LimFlow System represents a beacon of hope for those facing no other suitable treatment options, offering the potential to save limbs and drastically improve the quality of life for CLTI patients. ➡️ Check out a recent article in CNN about how LimFlow is offering hope to ‘no option’ patients facing amputation because of severe circulation problems: https://hubs.ly/Q021YdSb0 🚀The success of the LimFlow System is a testament to the unwavering dedication and innovative spirit of the team behind it. It's remarkable to see how this groundbreaking technology has the power to transform lives, reducing pain, promoting wound healing, and preventing major amputations. “At LimFlow, our vision is to achieve great outcomes for patients suffering from CLTI. We developed a novel way to make a vein function as an artery with the goal of saving limbs, and by doing that, saving patients’ lives,” said LimFlow CEO Dan Rose. “We thank the FDA for their collaborative review process and we look forward to introducing and expanding use of the LimFlow System in the U.S.” We are honored to be part of this journey, supporting the LimFlow team's vision; we look forward to witnessing the positive impact in the United States and beyond. ➡️ Read the full press release here: https://hubs.ly/Q021Ykkr0 Kinam Hong, M.D., MBA, CFA Dan Rose #HealthcareInnovation #FDAApproval #CLTI #SavingLives
-
